Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents
about
Micronutrient supplementation for children with HIV infectionMicronutrient supplementation in children and adults with HIV infectionVitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trialsImpact of vitamin D on infectious diseaseVitamin D supplementation for preventing infections in children under five years of age.Longitudinal changes in regional fat content in HIV-infected children and adolescents.LL-37 concentrations and the relationship to vitamin D, immune status, and inflammation in HIV-infected children and young adultsVitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals.Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapyCholecalciferol supplementation in HIV-infected youth with vitamin D insufficiency: effects on vitamin D status and T-cell phenotype: a randomized controlled trial.A Systematic Review of Nutritional Supplementation in HIV-Infected Children in Resource-Limited Settings.Determination of optimal vitamin D3 dosing regimens in HIV-infected paediatric patients using a population pharmacokinetic approach.High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial.Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women.The association of HIV status with bacterial vaginosis and vitamin D in the United States.Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial.Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.Bone health in HIV-infected children, adolescents and young adults: a systematic review.Younger age at HAART initiation is associated with more rapid growth reconstitution.Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.Vitamin D status in a Brazilian cohort of adolescents and young adults with perinatally acquired human immunodeficiency virus infection.Safety and Efficacy of High-Dose Daily Vitamin D3 Supplementation in Children and Young Adults Infected With Human Immunodeficiency VirusBone health in HIV-infected children and adolescents.Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youthNutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disorders.Vitamin D-related host genetic variants alter HIV disease progression in childrenVitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals.Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial.The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations.Translating the role of vitamin D3 in infectious diseases.How important is vitamin D in preventing infections?Bone health and human immunodeficiency virus infection.Role of vitamin D in acquired immune and autoimmune diseases.Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort Study.Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth.High prevalence of vitamin D deficiency in HIV-infected adults: what are the future research questions?Effect of high-dose cholecalciferol (vitamin D3) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial.Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder.Comprehensive Safety Monitoring of 12-Month Daily 7000-IU Vitamin D3 Supplementation in Human Immunodeficiency Virus-Infected Children and Young Adults.Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial.
P2860
Q24197503-669A2450-F8B5-4DA4-BFB8-203E6EB35E87Q24235504-DDA76B20-36F5-4F0C-AA6D-79DEB3BC424AQ24634794-439F0D98-4E86-449A-83BA-A1D1917C012AQ27000724-20E16DBB-F635-4735-AE47-FDC9673493E1Q30241581-281FA33B-11F7-434B-B71D-8E0D51312B6DQ33693051-3AFA919B-9E7E-4962-8F52-69E55E130246Q33828335-F0DAF88A-D5A8-4F91-B8FF-0B274BFDFAE0Q34016783-9577C487-DBA8-4612-81D5-F6D6EFB16821Q34328579-C6AADD1E-F35C-43AF-8548-F28CFABB9A9FQ34340891-34BA4E24-D707-4B60-A27B-EA9EB5E61223Q34425568-FD2575FE-6316-4276-A187-D665C6E44327Q34570942-599C92FE-B4AA-4285-B7A3-C136FDBC366CQ34799320-90BABC7D-BEEB-48DA-929C-45CA673DB05EQ35019046-AE652ED3-86BD-420F-9BF7-9E945D25B334Q35599536-F006D619-0293-423B-8ADB-D9EEB3365C87Q35753122-822100A7-1454-458F-B507-79CD1309A76AQ35815286-508E50E4-F397-4E9D-9D4A-B83B5D0AA519Q35822412-C9149F61-D8FD-4D16-B27D-EC4EA313769CQ36049040-9BB54D5D-4968-42F6-8BBB-62D2F7A9A283Q36361380-0932910F-1312-46BA-80E0-FE494E40F3D4Q36571072-3EF6B7AE-0DE9-4408-ABCA-B35796ED1CBAQ36862311-D2D1E40D-7E20-440C-93EB-E622296F438AQ36882631-C6F213CA-31F9-4163-B3FB-C813A5ABF74CQ37029416-E2B70136-468F-44E1-A1D6-B6675D069F04Q37244943-209755F8-A7F3-4CDD-8E1C-460BE6A0D26EQ37265049-C6310F79-B0E9-4DEF-AA76-B894D25E2F14Q37492503-C90614E2-80DB-4F56-9642-252B9110C428Q37504465-C2F118A2-0E16-4EED-BB91-431E5C42B727Q37838799-12E75404-B34B-49FB-B72E-F349720B39A5Q37981255-B2EFA121-D960-441B-8344-557DAE327C96Q38060570-6922469A-48B0-4854-9B3C-474EA314BE91Q38095828-C7AD32D4-EA15-4AA8-9121-2365C3A486C1Q38210581-560CF7A2-76C9-4F53-ABD9-B33379053208Q38844898-C2E3177E-51C9-4F24-BB93-2C930C4A4293Q38978858-2F7E48CA-254B-4454-A01E-AABDC05CD78CQ39673591-2F7E4FD8-67D8-4426-A6F1-E46BE905CC75Q40455005-D242B29C-EE69-472A-9A77-414A94876FD7Q40519915-23C05C6E-62C2-4CB8-8850-16D1A283DD0EQ41115518-D7864D1E-6043-4924-9E75-266186061CFCQ42050785-2DB26FBC-1D14-45A2-A874-23D77C7AF07B
P2860
Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effect of bimonthly supplement ...... ected children and adolescents
@ast
Effect of bimonthly supplement ...... ected children and adolescents
@en
Effect of bimonthly supplement ...... ected children and adolescents
@nl
type
label
Effect of bimonthly supplement ...... ected children and adolescents
@ast
Effect of bimonthly supplement ...... ected children and adolescents
@en
Effect of bimonthly supplement ...... ected children and adolescents
@nl
prefLabel
Effect of bimonthly supplement ...... ected children and adolescents
@ast
Effect of bimonthly supplement ...... ected children and adolescents
@en
Effect of bimonthly supplement ...... ected children and adolescents
@nl
P2093
P2860
P356
P1433
P1476
Effect of bimonthly supplement ...... ected children and adolescents
@en
P2093
Donald McMahon
Elizabeth Shane
Ellen S Engelson
Marukh Bamji
Mary Horlick
Murli Purswani
Stephen M Arpadi
P2860
P304
P356
10.1542/PEDS.2008-0176
P407
P577
2009-01-01T00:00:00Z